ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352741 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352741; 2) Community: the network communities that were significantly associated with the response to NSC 352741; 3) Molecule: the relationships between components within communities and NSC 352741; 4) MDR: the compounds that were significantly associated with the NSC 352741.

NSC Compound Enrichment Correlation
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0217366743178497 0.4292957
NSC 750050 Null 0.0217366743178497 0.37944742
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0217366743178497 0.17405691
NSC 752346 Null 0.0217366743178497 0.2725578
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0217366743178497 0.27898834
NSC 756375 GW811761X 0.0217366743178497 -0.05919847
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0217366743178497 0.34139408
NSC 93819 Depakine 0.0217366743178497 0.18726209
NSC 109154 Null 0.0219858755288753 0.55598618
NSC 130785 Null 0.0219858755288753 0.03867638
Total:89  Current:37    [First] [Prev] [Next] [Last]